202 related articles for article (PubMed ID: 36454486)
1. A case of fatal multidrug intoxication involving flualprazolam: distribution in body fluids and solid tissues.
Giorgetti A; Sommer MJ; Wilde M; Perdekamp MG; Auwärter V
Forensic Toxicol; 2022 Jan; 40(1):180-188. PubMed ID: 36454486
[TBL] [Abstract][Full Text] [Related]
2. Flualprazolam distribution in postmortem samples.
Ha HH; Mata DC
J Forensic Sci; 2022 Jan; 67(1):297-308. PubMed ID: 34585411
[TBL] [Abstract][Full Text] [Related]
3. Flualprazolam Blood Concentrations in 197 Forensic Investigation Cases.
Papsun DM; Krotulski AJ; Homan J; Temporal KDH; Logan BK
J Anal Toxicol; 2021 Mar; 45(3):226-232. PubMed ID: 32542312
[TBL] [Abstract][Full Text] [Related]
4. Flualprazolam: Report of an Outbreak of a New Psychoactive Substance in Adolescents.
Blumenberg A; Hughes A; Reckers A; Ellison R; Gerona R
Pediatrics; 2020 Jul; 146(1):. PubMed ID: 32581001
[TBL] [Abstract][Full Text] [Related]
5. Quantification of Flualprazolam in Blood by LC-MS-MS: A Case Series of Nine Deaths.
Rice K; Hikin L; Lawson A; Smith PR; Morley S
J Anal Toxicol; 2021 Apr; 45(4):410-416. PubMed ID: 32780842
[TBL] [Abstract][Full Text] [Related]
6. Femoral blood concentrations of flualprazolam in 33 postmortem cases.
Kriikku P; Rasanen I; Ojanperä I; Thelander G; Kronstrand R; Vikingsson S
Forensic Sci Int; 2020 Feb; 307():110101. PubMed ID: 31865266
[TBL] [Abstract][Full Text] [Related]
7. Flualprazolam and flubromazolam: Blood concentrations and prevalence of two novel psychoactive substances in forensic case work in Ontario, Canada.
Vekic N; Armstrong-Price D; Woodall K
J Anal Toxicol; 2023 Nov; 47(8):762-769. PubMed ID: 37930844
[TBL] [Abstract][Full Text] [Related]
8. Designer benzodiazepine rat pharmacokinetics: A comparison of alprazolam, flualprazolam and flubromazolam.
Canfield JR; Kisor DF; Sprague JE
Toxicol Appl Pharmacol; 2023 Apr; 465():116459. PubMed ID: 36907383
[TBL] [Abstract][Full Text] [Related]
9. Toxicokinetics and Analytical Toxicology of Flualprazolam: Metabolic Fate, Isozyme Mapping, Human Plasma Concentration and Main Urinary Excretion Products.
Wagmann L; Manier SK; Bambauer TP; Felske C; Eckstein N; Flockerzi V; Meyer MR
J Anal Toxicol; 2020 Jul; 44(6):549-558. PubMed ID: 32104896
[TBL] [Abstract][Full Text] [Related]
10. Increasing prevalence of designer benzodiazepines in impaired driving: A 5-year analysis from 2017 to 2021.
Papsun DM; Chan-Hosokawa A; Lamb ME; Logan B
J Anal Toxicol; 2023 Nov; 47(8):668-679. PubMed ID: 37338191
[TBL] [Abstract][Full Text] [Related]
11. Sensitive detection and primary metabolism analysis of flualprazolam in blood.
Ling J; Zhang W; Yan X; Liu W; Wang Y; Ding Y
J Forensic Leg Med; 2022 Aug; 90():102388. PubMed ID: 35691207
[TBL] [Abstract][Full Text] [Related]
12. Intoxications involving methoxyacetylfentanyl and U-47700: a study of 3 polydrug fatalities.
Giorgetti A; Große Perdekamp M; Franchetti G; Pircher R; Pollak S; Pelotti S; Auwärter V
Int J Legal Med; 2024 Jun; ():. PubMed ID: 38831139
[TBL] [Abstract][Full Text] [Related]
13. A Two-Year Evaluation of Flualprazolam Concentrations in Orange County Drivers: Effects on Driving and Field Sobriety Test Performance.
Manaloto FR; Meneses VM; Mata DC
J Anal Toxicol; 2023 Jan; 46(9):1038-1044. PubMed ID: 35244711
[TBL] [Abstract][Full Text] [Related]
14. Designer Benzodiazepines: A Review of Toxicology and Public Health Risks.
Brunetti P; Giorgetti R; Tagliabracci A; Huestis MA; Busardò FP
Pharmaceuticals (Basel); 2021 Jun; 14(6):. PubMed ID: 34208284
[TBL] [Abstract][Full Text] [Related]
15. Urine Drug Screening in the Era of Designer Benzodiazepines: Comparison of Three Immunoassay Platforms, LC-QTOF-MS and LC-MS-MS.
Puzyrenko A; Wang D; Schneider R; Wallace G; Schreiber S; Brandt K; Gunsolus IL
J Anal Toxicol; 2022 Aug; 46(7):712-718. PubMed ID: 34557900
[TBL] [Abstract][Full Text] [Related]
16. A New Strategy for Efficient Retrospective Data Analyses for Designer Benzodiazepines in Large LC-HRMS Datasets.
Pan M; Rasmussen BS; Dalsgaard PW; Mollerup CB; Nielsen MKK; Nedahl M; Linnet K; Mardal M
Front Chem; 2022; 10():868532. PubMed ID: 35692684
[TBL] [Abstract][Full Text] [Related]
17. Challenges of Diagnosing and Managing Designer Benzodiazepine Dependence and Withdrawal: A Case Report.
Peng L; Lawrence D; Levander XA
J Addict Med; 2022 Mar-Apr 01; 16(2):249-251. PubMed ID: 34001772
[TBL] [Abstract][Full Text] [Related]
18. Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer.
El Balkhi S; Chaslot M; Picard N; Dulaurent S; Delage M; Mathieu O; Saint-Marcoux F
Int J Legal Med; 2017 Jul; 131(4):979-988. PubMed ID: 28160051
[TBL] [Abstract][Full Text] [Related]
19. 'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports.
Orsolini L; Corkery JM; Chiappini S; Guirguis A; Vento A; De Berardis D; Papanti D; Schifano F
Curr Neuropharmacol; 2020; 18(9):809-837. PubMed ID: 31933443
[TBL] [Abstract][Full Text] [Related]
20. A Fatal Case Report Resulting from the Abuse of the Designer Benzodiazepines Clonazolam and Flualprazolam in Conjunction with Dried Opium Poppy Pods‡.
Theofel N; Möller P; Vejmelka E; Kramer C; Tsokos M; Scholtis S
J Anal Toxicol; 2023 Jan; 46(9):e285-e290. PubMed ID: 36516236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
